UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.43 billion. The enterprise value is $1.57 billion.
| Market Cap | 1.43B |
| Enterprise Value | 1.57B |
Important Dates
The next confirmed earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.37 million shares outstanding. The number of shares has increased by 47.48% in one year.
| Current Share Class | 54.37M |
| Shares Outstanding | 54.37M |
| Shares Change (YoY) | +47.48% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 2.93% |
| Owned by Institutions (%) | 70.79% |
| Float | 45.92M |
Valuation Ratios
The trailing PE ratio is 35.16 and the forward PE ratio is 27.19. UTI's PEG ratio is 1.81.
| PE Ratio | 35.16 |
| Forward PE | 27.19 |
| PS Ratio | 1.78 |
| Forward PS | 1.76 |
| PB Ratio | 5.45 |
| P/TBV Ratio | 6.71 |
| P/FCF Ratio | 23.27 |
| P/OCF Ratio | 16.69 |
| PEG Ratio | 1.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.71, with an EV/FCF ratio of 25.42.
| EV / Earnings | 41.16 |
| EV / Sales | 2.14 |
| EV / EBITDA | 17.71 |
| EV / EBIT | 26.50 |
| EV / FCF | 25.42 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.13.
| Current Ratio | 1.08 |
| Quick Ratio | 0.94 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 4.79 |
| Interest Coverage | 6.24 |
Financial Efficiency
Return on equity (ROE) is 17.28% and return on invested capital (ROIC) is 6.53%.
| Return on Equity (ROE) | 17.28% |
| Return on Assets (ROA) | 4.97% |
| Return on Capital (ROIC) | 6.53% |
| Revenue Per Employee | $198,024 |
| Profits Per Employee | $10,284 |
| Employee Count | 3,700 |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $14.23 million in taxes.
| Income Tax | 14.23M |
| Effective Tax Rate | 25.30% |
Stock Price Statistics
The stock price has increased by +89.03% in the last 52 weeks. The beta is 1.45, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +89.03% |
| 50-Day Moving Average | 24.41 |
| 200-Day Moving Average | 18.18 |
| Relative Strength Index (RSI) | 59.39 |
| Average Volume (20 Days) | 436,683 |
Short Selling Information
The latest short interest is 1.86 million, so 3.42% of the outstanding shares have been sold short.
| Short Interest | 1.86M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 3.42% |
| Short % of Float | 4.05% |
| Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, UTI had revenue of $732.69 million and earned $38.05 million in profits. Earnings per share was $0.75.
| Revenue | 732.69M |
| Gross Profit | 400.62M |
| Operating Income | 59.09M |
| Pretax Income | 40.10M |
| Net Income | 38.05M |
| EBITDA | 88.42M |
| EBIT | 59.09M |
| Earnings Per Share (EPS) | $0.75 |
Balance Sheet
The company has $162.40 million in cash and $294.75 million in debt, giving a net cash position of -$132.35 million or -$2.43 per share.
| Cash & Cash Equivalents | 162.40M |
| Total Debt | 294.75M |
| Net Cash | -132.35M |
| Net Cash Per Share | -$2.43 |
| Equity (Book Value) | 260.23M |
| Book Value Per Share | 4.84 |
| Working Capital | 16.99M |
Cash Flow
In the last 12 months, operating cash flow was $85.90 million and capital expenditures -$24.30 million, giving a free cash flow of $61.60 million.
| Operating Cash Flow | 85.90M |
| Capital Expenditures | -24.30M |
| Free Cash Flow | 61.60M |
| FCF Per Share | $1.13 |
Margins
Gross margin is 54.68%, with operating and profit margins of 8.06% and 5.73%.
| Gross Margin | 54.68% |
| Operating Margin | 8.06% |
| Pretax Margin | 7.67% |
| Profit Margin | 5.73% |
| EBITDA Margin | 12.07% |
| EBIT Margin | 8.06% |
| FCF Margin | 8.41% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.48% |
| Shareholder Yield | -47.48% |
| Earnings Yield | 2.65% |
| FCF Yield | 4.30% |
Analyst Forecast
The average price target for UTI is $27.17, which is 3.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.17 |
| Price Target Difference | 3.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 2.24 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 7 |